Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 16, Issue -, Pages 4373-4390
Publisher
Informa UK Limited
Online
2021-06-29
DOI
10.2147/ijn.s305851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Learning from the Past: a Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease
- (2020) Kelly Ceyzériat et al. Current Alzheimer Research
- Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease
- (2020) Hussein Akel et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer’s disease
- (2020) Andrea Haake et al. Expert Opinion On Drug Safety
- Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's
- (2020) Prabhuti Nirale et al. LIFE SCIENCES
- Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives
- (2020) Kévin Beccaria et al. Neurosurgical Focus
- Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
- (2020) William M. Pardridge Frontiers in Aging Neuroscience
- Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
- (2020) Balmiki Ray et al. Translational Psychiatry
- Nose-to-Brain Delivery
- (2020) Paolo Giunchedi et al. Pharmaceutics
- Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands
- (2020) Aida Iraji et al. BIOORGANIC CHEMISTRY
- Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease
- (2020) R.G.R Pinheiro et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review
- (2020) S. Cunha et al. Nanomedicine-Nanotechnology Biology and Medicine
- Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment
- (2020) Thomas Adnet et al. Pharmaceutics
- Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
- (2020) Mohamed Haider et al. Pharmaceutics
- The Role of Selected Bioactive Compounds in the Prevention of Alzheimer’s Disease
- (2020) Wojciech Grodzicki et al. Antioxidants
- Recent advances in encapsulation of curcumin in nanoemulsions: A review of encapsulation technologies, bioaccessibility and applications
- (2020) Tian Jiang et al. FOOD RESEARCH INTERNATIONAL
- Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters
- (2020) Sara Cunha et al. Pharmaceutics
- The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease
- (2019) Jing Zhi A. Tan et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- A short perspective on the long road to effective treatments for Alzheimer's disease.
- (2019) David S. Reynolds BRITISH JOURNAL OF PHARMACOLOGY
- Nanoemulsions for “Nose-to-Brain” Drug Delivery
- (2019) Maria Bonferoni et al. Pharmaceutics
- Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
- (2019) Darshpreet Kaur et al. INFLAMMOPHARMACOLOGY
- The amyloid cascade and Alzheimer’s disease therapeutics: theory versus observation
- (2019) Rudy J. Castellani et al. LABORATORY INVESTIGATION
- Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis
- (2019) C. Costa et al. JOURNAL OF CONTROLLED RELEASE
- Present Algorithms and Future Treatments for Alzheimer’s Disease
- (2019) George T. Grossberg et al. JOURNAL OF ALZHEIMERS DISEASE
- Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges
- (2019) Zahra Karami et al. DRUG DISCOVERY TODAY
- Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer’s disease using Box-Behnken design
- (2019) Gifty M. Jojo et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies
- (2019) Dnyandev G. Gadhave et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Systemic and CNS inflammation crosstalk: implications for Alzheimer’s Disease
- (2019) Evi Paouri et al. Current Alzheimer Research
- Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia
- (2019) Jee-young Han et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Neuroinflammation in mild cognitive impairment and Alzheimer’s disease: A meta-analysis
- (2019) Steven Bradburn et al. AGEING RESEARCH REVIEWS
- Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications
- (2019) Andrea Cabrera‐Pastor et al. Acta Physiologica
- Inflammasomes in neuroinflammatory and neurodegenerative diseases
- (2019) Sofie Voet et al. EMBO Molecular Medicine
- Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective
- (2019) Georgette L. Suidan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Current and Future Treatments in Alzheimer's Disease
- (2019) Alireza Atri SEMINARS IN NEUROLOGY
- Release mechanism of lipid nanoparticles immobilized within alginate beads influenced by nanoparticle size and alginate concentration
- (2019) Rui Sun et al. COLLOID AND POLYMER SCIENCE
- Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges
- (2019) Bappaditya Chatterjee et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: Formulation, optimization and in vivo characterization
- (2019) Amarjitsing P. Rajput et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Cholinesterase inhibitors as Alzheimer's therapeutics (Review)
- (2019) Kamlesh Sharma Molecular Medicine Reports
- Glioprotective Effect of Chitosan-Coated Rosmarinic Acid Nanoemulsions Against Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Rat Astrocyte Primary Cultures
- (2019) Flávia Nathiely Silveira Fachel et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Multi-target design strategies for the improved treatment of Alzheimer's disease
- (2019) Pengfei Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nutrients in the Prevention of Alzheimer’s Disease
- (2019) Anna Laura Cremonini et al. Oxidative Medicine and Cellular Longevity
- The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease
- (2019) Alessandra Webers et al. IMMUNOLOGY AND CELL BIOLOGY
- Strategies to facilitate or block nose-to-brain drug delivery
- (2019) Patricia P. Martins et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease
- (2019) Sofie Lautrup et al. NEUROCHEMISTRY INTERNATIONAL
- Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
- (2019) Soon-Seok Hong et al. Pharmaceutics
- Perivascular and Perineural Pathways Involved in Brain Delivery and Distribution of Drugs after Intranasal Administration
- (2019) Jeffrey J. Lochhead et al. Pharmaceutics
- Nanoemulsions and thermosensitive nanoemulgels of phenytoin and fosphenytoin for intranasal administration: Formulation development and in vitro characterization
- (2019) Patrícia C. Pires et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives
- (2019) Helena Bigares Grangeia et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The p53 inactivators pifithrin-μ and pifithrin-α mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy
- (2019) Ling-Yu Yang et al. EXPERIMENTAL NEUROLOGY
- A resurrection of aducanumab for Alzheimer's disease
- (2019) Lon Schneider LANCET NEUROLOGY
- Overcoming the Brain Barriers: From Immune Cells to Nanoparticles
- (2019) Marc Charabati et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia
- (2019) Niyaz Ahmad et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Intranasal Lipid Nanoparticles for the Treatment of Neurodegenerative Diseases
- (2018) S. Cunha et al. CURRENT PHARMACEUTICAL DESIGN
- Silymarin loaded nanostructured lipid carrier: From design and dermatokinetic study to mechanistic analysis of epidermal drug deposition enhancement
- (2018) Babar Iqbal et al. JOURNAL OF MOLECULAR LIQUIDS
- The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review
- (2018) Marta Sochocka et al. MOLECULAR NEUROBIOLOGY
- Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation
- (2018) Mohammed Elmowafy et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus
- (2018) Helen C. Kales et al. INTERNATIONAL PSYCHOGERIATRICS
- Dissociable effects of the apolipoprotein-E (APOE) gene on short and long-term memories
- (2018) Nahid Zokaei et al. NEUROBIOLOGY OF AGING
- Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease
- (2018) M. Tzioras et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Blood-Brain Barrier: From Physiology to Disease and Back
- (2018) Melanie D. Sweeney et al. PHYSIOLOGICAL REVIEWS
- Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
- (2018) Piyoosh Sharma et al. PROGRESS IN NEUROBIOLOGY
- Sucrose stearate as a biosurfactant for development of rivastigmine containing nanostructured lipid carriers and assessment of its activity against dementia in C. elegans model
- (2018) Anubhav Anand et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Attenuation of oxidative stress induced mitochondrial dysfunction and cytotoxicity in fibroblast cells by sulfated polysaccharide from Padina gymnospora
- (2018) Raguraman Vasantharaja et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule?
- (2017) Melania Maria Serafini et al. PHARMACOLOGICAL RESEARCH
- Vitamin D, Cognition and Alzheimer’s Disease: The Therapeutic Benefit is in the D-Tails
- (2016) Véréna Landel et al. JOURNAL OF ALZHEIMERS DISEASE
- Nanostructured lipid carriers: Promising drug delivery systems for future clinics
- (2016) Ana Beloqui et al. Nanomedicine-Nanotechnology Biology and Medicine
- Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters
- (2015) Brijesh Shah et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, andin vivostudy
- (2014) Rohini G. Madane et al. DRUG DELIVERY
- Current Progresses on Nanodelivery Systems for the Treatment of Neuropsychiatric Diseases: Alzheimer’s and Schizophrenia
- (2013) A.C. Silva et al. CURRENT PHARMACEUTICAL DESIGN
- Lipid-based Nanocarriers As An Alternative for Oral Delivery of Poorly Water- Soluble Drugs: Peroral and Mucosal Routes
- (2012) A. C. Silva et al. CURRENT MEDICINAL CHEMISTRY
- Intranasal administration of nanostructured lipid carriers containing CNS acting drug: Pharmacodynamic studies and estimation in blood and brain
- (2012) M. Intakhab Alam et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
- (2008) Leah R Hanson et al. BMC NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now